Intracrine and Metabolic Tumor Adaptation Under Androgen Deprivation

Androgen deprivation therapy (ADT) remains a cornerstone of prostate cancer treatment. It slows tumor growth but also triggers complex intracellular and metabolic response pathways. These tumor adaptations, which significantly influence the course of the disease, open up new possibilities for personalized treatment approaches.